ResearcherNational and Kapodistrian University of AthensActive in the last 2 years

Dimitrios C. Ziogas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2620-4004; OpenAlex author ID A5058973451. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

Uncovering Pathogenic Variants in Cancer Susceptibility Genes through Genetic Testing for Pancreatic Cancer Patients Co-author DOI 10.20944/preprints202403.1473.v1 ↗
Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genom… Co-author DOI 10.3390/cancers16010002 ↗
Immunotherapy for pancreatic cancer: A 2020 update. Co-author DOI 10.1016/j.ctrv.2020.102016 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

George Nasioulas · 2 shared papers, 2023–2024 · strength 0.31
- Paper Uncovering Pathogenic Variants in Cancer Susceptibility Genes through Genetic Testing for Pancreatic Cancer Patients DOI 10.20944/preprints202403.1473.v1 ↗
- Paper Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic D… DOI 10.3390/cancers16010002 ↗
Kevisa Potska · 1 shared paper, 2024 · strength 0.16
- Paper Uncovering Pathogenic Variants in Cancer Susceptibility Genes through Genetic Testing for Pancreatic Cancer Patients DOI 10.20944/preprints202403.1473.v1 ↗
Mustafa Özdoğan · 1 shared paper, 2024 · strength 0.16
- Paper Uncovering Pathogenic Variants in Cancer Susceptibility Genes through Genetic Testing for Pancreatic Cancer Patients DOI 10.20944/preprints202403.1473.v1 ↗
Evangelos S. Felekouras · 1 shared paper, 2023 · strength 0.14
- Paper Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic D… DOI 10.3390/cancers16010002 ↗
Stratigoula Sakellariou · 1 shared paper, 2023 · strength 0.14
- Paper Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic D… DOI 10.3390/cancers16010002 ↗
Ioannis Boukovinas · 1 shared paper, 2023 · strength 0.14
- Paper Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic D… DOI 10.3390/cancers16010002 ↗
Charalampos Theocharopoulos · 1 shared paper, 2023 · strength 0.14
- Paper Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic D… DOI 10.3390/cancers16010002 ↗
Evangelos Koustas · 1 shared paper, 2020 · strength 0.11
- Paper Immunotherapy for pancreatic cancer: A 2020 update. DOI 10.1016/j.ctrv.2020.102016 ↗
Michalis V. Karamouzis · 1 shared paper, 2020 · strength 0.11
- Paper Immunotherapy for pancreatic cancer: A 2020 update. DOI 10.1016/j.ctrv.2020.102016 ↗
Christo Kole · 1 shared paper, 2020 · strength 0.11
- Paper Immunotherapy for pancreatic cancer: A 2020 update. DOI 10.1016/j.ctrv.2020.102016 ↗
Dimitriοs Schizas · 1 shared paper, 2020 · strength 0.11
- Paper Immunotherapy for pancreatic cancer: A 2020 update. DOI 10.1016/j.ctrv.2020.102016 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.